These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 38635528)

  • 41. Construction of a novel mRNAsi-related risk model for predicting prognosis and immunotherapy response in osteosarcoma.
    Li Z; Jin C; Lu X; Zhang Y; Zhang Y; Wen J; Liu Y; Liu X; Li J
    Ann Transl Med; 2023 Jan; 11(2):61. PubMed ID: 36819514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic prediction and multidimensional dissections of a macrophages M0-related gene signature in liver cancer.
    Xu X; Wang J
    Front Endocrinol (Lausanne); 2023; 14():1153562. PubMed ID: 37033261
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systematic Analysis of Tumor Stem Cell-related Gene Characteristics to Predict the PD-L1 Immunotherapy and Prognosis of Gastric Cancer.
    Wang C; Chen Y; Zhou R; Yang Y; Fang Y
    Curr Med Chem; 2024; 31(17):2467-2482. PubMed ID: 37936456
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Li Y; Zheng P; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of potential crucial genes associated with the pathogenesis and prognosis of liver hepatocellular carcinoma.
    Shi L; Shang X; Nie K; Lin Z; Zheng M; Wang M; Yuan H; Zhu Z
    J Clin Pathol; 2021 Aug; 74(8):504-512. PubMed ID: 33004423
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combining bulk and single-cell RNA-sequencing data to develop an NK cell-related prognostic signature for hepatocellular carcinoma based on an integrated machine learning framework.
    Feng Q; Huang Z; Song L; Wang L; Lu H; Wu L
    Eur J Med Res; 2023 Aug; 28(1):306. PubMed ID: 37649103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival.
    Liu P; Dong C; Shi H; Yan Z; Zhang J; Liu J
    J Gastrointest Oncol; 2022 Dec; 13(6):3169-3182. PubMed ID: 36636051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
    Wang R; Hu X; Liu X; Bai L; Gu J; Li Q
    PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD93 overexpresses in liver hepatocellular carcinoma and represents a potential immunotherapy target.
    Jiang Q; Kuai J; Jiang Z; Que W; Wang P; Huang W; Ding W; Zhong L
    Front Immunol; 2023; 14():1158360. PubMed ID: 37483608
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and validation of multi-omic prognostic signature of anoikis-related genes in liver hepatocellular carcinoma.
    Ding D; Wang D; Qin Y
    Medicine (Baltimore); 2023 Nov; 102(46):e36190. PubMed ID: 37986299
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma.
    Jin W; Wang G; Dong M; Wang X
    Eur J Med Res; 2024 Mar; 29(1):177. PubMed ID: 38494503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Integrated Single-cell and Transcriptome Sequencing Analyses Identified PREX1 as an Immune-related Prognostic Biomarker for Liver Hepatocellular Carcinoma.
    Yang J; Fan LY; Shi KY
    Int J Med Sci; 2024; 21(8):1559-1574. PubMed ID: 38903921
    [No Abstract]   [Full Text] [Related]  

  • 53. Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on NK cell marker genes to predict prognosis and immunotherapy response in hepatocellular carcinoma.
    Yang D; Zhao F; Su Y; Zhou Y; Shen J; Yu B; Zhao K; Ding Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10609-10621. PubMed ID: 37296316
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of the Prognosis and Tumor Microenvironment of Cellular Senescence-related Genes through scRNA-seq and Bulk RNA-seq Analysis in GC.
    Guo G; Zhou Z; Chen S; Cheng J; Wang Y; Lan T; Ye Y
    Recent Pat Anticancer Drug Discov; 2024; 19(4):530-542. PubMed ID: 37807645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Wang Y; Han Y; Jin L; Ji L; Liu Y; Lin M; Zhou S; Yang R
    Aging (Albany NY); 2024 Apr; 16(8):7293-7310. PubMed ID: 38656879
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of Cancer Stem Cell Characteristics and Development of a Prognostic Stemness Index Cell-Related Signature in Oral Squamous Cell Carcinoma.
    Feng J; Li Y; Wen N
    Dis Markers; 2021; 2021():1571421. PubMed ID: 34840626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comprehensive analysis of N
    Zhu HX; Lu WJ; Zhu WP; Yu S
    J Clin Lab Anal; 2021 Dec; 35(12):e24071. PubMed ID: 34741346
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of PPAR-related differentially expressed genes liver hepatocellular carcinoma and construction of a prognostic model based on data analysis and molecular docking.
    Wang Y; Li S; Liu Z; Li X; Yu Y; Liu H
    J Cell Mol Med; 2024 Apr; 28(8):e18304. PubMed ID: 38652093
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Construction and validation of a prognostic marker and risk model for HCC ultrasound therapy combined with WGCNA identification.
    Bi Y; Jing Y; Guo L
    Front Genet; 2022; 13():1017551. PubMed ID: 36263426
    [No Abstract]   [Full Text] [Related]  

  • 60. Vesicle-mediated transport-related genes predict the prognosis and immune microenvironment in hepatocellular carcinoma.
    Ye Z; Wang Y; Yuan R; Ding R; Hou Y; Qian L; Zhang S
    J Cancer; 2024; 15(12):3645-3662. PubMed ID: 38911369
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.